Abstract
Objective: In the current research study, a colon targeted pulsatile drug delivery system (PDDS) of venlafaxine hydrochloride (VH) was designed for chronotherapy of depression.
Method: A capsular device was designed having body insoluble throughout gastrointestinal tract (GIT) fluid and cap soluble in small intestine fluid. The granules of VH was filled in the body and separated from the cap with the help of a hydrophilic polymer plug. Plugs were made up of blend of HPMC K100M and xanthan gum (1:1). Finally, an enteric coating was applied on entire capsule using 5 %w/v ethylcellulose (EC) solution. Results: In in vitro release studies, the enteric coat of the EC was insoluble for 2 h in pH 1.2 (stomach), but get solubilized in pH 7.4 phosphate buffer (small intestine). The cap of the capsule solubilizes in pH 7.4, which exposed the hydrophilic plug to absorb the nearby fluid and swell. After maximum swelling, the plugs got ejected out from the capsule body causing the release of VH granules into colon (pH 6.8 phosphate buffer). Conclusion: Formulations containing high amount of polymer in plug showed 5 h lag time, which was considered optimum for a delivery system to reach colon and release the drug.Keywords: Pulsatile, chronotherapy, colon, venlafaxine, depression, HPMC, xanthan gum.
Graphical Abstract
Current Psychopharmacology
Title:Colon Targeted Pulsatile Drug Delivery System of Venlafaxine Hydrochloride for Treatment of Depression
Volume: 6
Author(s): Ajay Kumar, Ankaj Kaundal, Mahendra S. Ashawat, Vinay Pandit and Pravin Kumar*
Affiliation:
- Department of Pharmaceutics, Laureate Institute of Pharmacy, VPO-Kathog, Tehsil- Dehra, Distt.-Kangra, H.P-177101,India
Keywords: Pulsatile, chronotherapy, colon, venlafaxine, depression, HPMC, xanthan gum.
Abstract: Objective: In the current research study, a colon targeted pulsatile drug delivery system (PDDS) of venlafaxine hydrochloride (VH) was designed for chronotherapy of depression.
Method: A capsular device was designed having body insoluble throughout gastrointestinal tract (GIT) fluid and cap soluble in small intestine fluid. The granules of VH was filled in the body and separated from the cap with the help of a hydrophilic polymer plug. Plugs were made up of blend of HPMC K100M and xanthan gum (1:1). Finally, an enteric coating was applied on entire capsule using 5 %w/v ethylcellulose (EC) solution. Results: In in vitro release studies, the enteric coat of the EC was insoluble for 2 h in pH 1.2 (stomach), but get solubilized in pH 7.4 phosphate buffer (small intestine). The cap of the capsule solubilizes in pH 7.4, which exposed the hydrophilic plug to absorb the nearby fluid and swell. After maximum swelling, the plugs got ejected out from the capsule body causing the release of VH granules into colon (pH 6.8 phosphate buffer). Conclusion: Formulations containing high amount of polymer in plug showed 5 h lag time, which was considered optimum for a delivery system to reach colon and release the drug.Export Options
About this article
Cite this article as:
Kumar Ajay, Kaundal Ankaj, Ashawat S. Mahendra, Pandit Vinay and Kumar Pravin*, Colon Targeted Pulsatile Drug Delivery System of Venlafaxine Hydrochloride for Treatment of Depression, Current Psychopharmacology 2017; 6 (1) . https://dx.doi.org/10.2174/2211556006666161221113127
DOI https://dx.doi.org/10.2174/2211556006666161221113127 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Production of Reactive Oxygen Species from Aggregating Proteins Implicated in Alzheimers Disease, Parkinsons Disease and Other Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Glia: An Important Target for Anti-Inflammatory and Antidepressant Activity
Current Drug Targets On the Sympathetic Innervation of the Human Greater Saphenous Vein: Relevance to Clinical Practice
Current Vascular Pharmacology Structure-based Approaches Targeting Parasite Cysteine Proteases
Current Medicinal Chemistry β-Amyloid, Neuronal Death and Alzheimers Disease
Current Molecular Medicine Neuro-Psychological Pattern in Patients Suffering from Primitive Dilated Cardiomyopathy with Impairment in Executive Function
Current Neurovascular Research Peripheral Neuropathy Induced by Paclitaxel: Recent Insights and Future Perspectives
Current Neuropharmacology Abnormalities in Kynurenine Pathway Metabolism in Treatment-Resistant Depression and Suicidality: A Systematic Review
CNS & Neurological Disorders - Drug Targets Calcium Handling and Arrhythmogenesis
Medicinal Chemistry Nogo Receptor Interacts with Brain APP and Aβ to Reduce Pathologic Changes in Alzheimers Transgenic Mice
Current Alzheimer Research Nicotine Effects, Body Weight Concerns and Smoking: A Literature Review
Current Pharmaceutical Design Endothelial Chemokines in Autoimmune Disease
Current Pharmaceutical Design The Role of the Endothelium in Premature Atherosclerosis: Molecular Mechanisms
Current Medicinal Chemistry Structural Neuroimaging Findings in Major Depressive Disorder Throughout Aging: A Critical Systematic Review of Prospective Studies
CNS & Neurological Disorders - Drug Targets Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses
Cardiovascular & Hematological Agents in Medicinal Chemistry The Serum Protein and Lipid Oxidation Marker Levels in Alzheimers Disease and Effects of Cholinesterase Inhibitors and Antipsychotic Drugs Therapy
Current Alzheimer Research Endocannabinoids in Liver Disease and Hepatic Encephalopathy
Current Pharmaceutical Design Developmental and Biological Insights Obtained from Gene Expression Profiling of the Nematode Caenorhabditis Elegans
Current Genomics Critical Role of the Endocannabinoid System in the Regulation of Food Intake and Energy Metabolism, with Phylogenetic, Developmental, and Pathophysiological Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets Parvalbumin as a Pleomorphic Protein
Current Protein & Peptide Science